NDC 73604-914

Arcalyst

Rilonacept

Arcalyst is a Subcutaneous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Kiniksa Pharmaceuticals (uk), Ltd.. The primary component is Rilonacept.

• Product ID: 73604-914_10355833-5e51-4efa-9cdf-49dba3b58e47
• NDC: 73604-914
• Product Type: Human Prescription Drug
• Proprietary Name: Arcalyst
• Generic Name: Rilonacept
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2008-02-27
• Marketing Category: BLA /
• Application Number: BLA125249
• Labeler Name: Kiniksa Pharmaceuticals (UK), Ltd.
• Substance Name: RILONACEPT
• Active Ingredient Strength: 160 mg/2mL
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 73604-914-01

1 VIAL, SINGLE-USE in 1 CARTON (73604-914-01) > 2 mL in 1 VIAL, SINGLE-USE

• Marketing Start Date: 2021-06-18
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Arcalyst" or generic name "Rilonacept"

NDC	Brand Name	Generic Name
61755-001	Arcalyst	rilonacept
73604-914	Arcalyst	rilonacept